Display options
Cite
Laginestra MA, Cascione L, Motta G, et al. Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Mod Pathol. 2020;33(2):319doi: 10.1038/s41379-019-0376-8.
Laginestra, M. A., Cascione, L., Motta, G., Fuligni, F., Agostinelli, C., Rossi, M., Sapienza, M. R., Righi, S., Broccoli, A., Indio, V., Melle, F., Tabanelli, V., Calleri, A., Novero, D., Facchetti, F., Inghirami, G., Sabattini, E., Bertoni, F., & Pileri, S. A. (2020). Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 33(2), 319. https://doi.org/10.1038/s41379-019-0376-8
Laginestra, Maria Antonella, et al. "Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 33,2 (2020): 319. doi: https://doi.org/10.1038/s41379-019-0376-8
Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA. Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Mod Pathol. 2020 Feb;33(2):319. doi: 10.1038/s41379-019-0376-8. PMID: 31558781; PMCID: PMC7608231.
Copy Download .nbib Format: NLM
Share it on

Mod Pathol. 2020 Feb;33(2):319. doi: 10.1038/s41379-019-0376-8.

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Maria Antonella Laginestra, Luciano Cascione, Giovanna Motta, Fabio Fuligni, Claudio Agostinelli, Maura Rossi, Maria Rosaria Sapienza, Simona Righi, Alessandro Broccoli, Valentina Indio, Federica Melle, Valentina Tabanelli, Angelica Calleri, Domenico Novero, Fabio Facchetti, Giorgio Inghirami, Elena Sabattini, Francesco Bertoni, Stefano A Pileri

Affiliations

  1. Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy. [email protected].
  2. Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  3. Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  4. Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
  5. Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.
  6. Division of Cancer Research Center "Giorgio Prodi" University of Bologna, Bologna, Italy.
  7. Division of Pathological Anatomy, Quality and Safety of Diagnosis and Treatment, Città della Salute e della Scienza, Turin, Italy.
  8. Division of Pathology Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy.
  9. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
  10. Division of Haematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy. [email protected].

PMID: 31558781 PMCID: PMC7608231 DOI: 10.1038/s41379-019-0376-8

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication Types